Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 1863 entries
View as:

A Study of Olaparib and Pembrolizumab in People with Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05203445 Org: User:
Start: 01/31/22 End: 01/31/26 Due: 01/31/27

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03069326 Org: User:
Start: 02/27/17 End: 02/28/26 Due: 02/28/27

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04165772 Org: User:
Start: 12/11/19 End: 11/30/26 Due: 11/30/27

Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03276481 Org: User:
Start: 08/28/17 End: 07/12/23 Due: 07/12/24

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Phase: N/A Priority: Normal
NCT ID: NCT01888198 Org: User:
Start: 06/30/13 End: 06/30/25 Due: 06/30/26

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00580203 Org: User:
Start: 02/29/04 End: 11/12/24 Due: 11/12/25

Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00450307 Org: User:
Start: 06/30/05 End: 04/30/13 Due: 04/30/14

Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo

Phase: N/A Priority: Normal
NCT ID: NCT03004053 Org: User:
Start: 12/31/16 End: 02/28/22 Due: 02/28/23

LY293111 in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00006375 Org: User:
Start: 06/30/00 End: 02/28/03 Due: 02/28/04

Germ Cell Tumor and Testicular Tumor DNA Registry

Phase: N/A Priority: Normal
NCT ID: NCT02099734 Org: User:
Start: 01/31/14 End: 01/31/26 Due: 01/31/27

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05169970 Org: User:
Start: 12/09/21 End: 12/31/26 Due: 12/31/27

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04683679 Org: User:
Start: 04/21/21 End: 01/31/26 Due: 01/31/27

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05393804 Org: User:
Start: 05/20/22 End: 05/31/26 Due: 05/31/27

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06057948 Org: User:
Start: 09/21/23 End: 03/21/26 Due: 03/21/27

Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03813615 Org: User:
Start: 01/21/19 End: 01/31/26 Due: 01/31/27

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03093922 Org: User:
Start: 03/22/17 End: 03/31/26 Due: 03/31/27

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01430390 Org: User:
Start: 09/30/11 End: 09/30/26 Due: 09/30/27

Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT04016376 Org: User:
Start: 07/05/19 End: 07/31/26 Due: 07/31/27

Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis

Phase: N/A Priority: Normal
NCT ID: NCT01052766 Org: User:
Start: 01/31/10 End: 03/31/12 Due: 03/31/13

A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05156268 Org: User:
Start: 01/27/22 End: 01/31/26 Due: 01/31/27

Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00494910 Org: User:
Start: 06/26/07 End: 03/05/24 Due: 03/05/25

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Phase: N/A Priority: Normal
NCT ID: NCT00423514 Org: User:
Start: 11/20/06 End: 06/18/21 Due: 06/18/22

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT02145871 Org: User:
Start: 05/21/14 End: 03/14/24 Due: 03/14/25

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002982 Org: User:
Start: 01/31/97 End: 10/31/05 Due: 10/31/06

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05672524 Org: User:
Start: 12/30/22 End: 12/30/25 Due: 12/30/26